ABVC BioPharma, Inc. (ABVC) vs Context Therapeutics Inc. (CNTX)

A side-by-side comparison of ABVC BioPharma, Inc. and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABVC

ABVC BioPharma, Inc.

$25M

$0.97HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

CNTX

Context Therapeutics Inc.

$32M

$0.35HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ABVC vs CNTX

growth of $100 · dividends reinvested · last 5y

ABVC -95.8% (-47.0%/yr)CNTX -93.4% (-41.9%/yr)CNTX compounded faster over this window

ABVC CNTX

ABVC vs CNTX: by the numbers

•CNTX is the larger company ($32M vs $25M market cap).

Metrics side by side

Valuation

Metric	ABVC	CNTX
P/B ratio	2.44	0.85

Profitability

Metric	ABVC	CNTX
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-76.82%	-120.40%
ROIC	-53.34%	-126.84%

Growth (annualized)

Metric	ABVC	CNTX
Total return CAGR (5Y)	-46.33%	N/A

Go deeper

Full ABVC analysis Full CNTX analysis Interactive comparison tool

Dig into the metrics

ABVC BioPharma ROE Context Therapeutics ROE ABVC BioPharma operating margin Context Therapeutics operating margin ABVC BioPharma revenue growth Context Therapeutics revenue growth ABVC BioPharma free cash flow Context Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.